➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Johnson and Johnson
Dow
McKinsey
Merck

Last Updated: January 21, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Lysergic Acid Diethylamide

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Lysergic Acid Diethylamide?

Lysergic Acid Diethylamide is an investigational drug.

There have been 15 clinical trials for Lysergic Acid Diethylamide. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2019.

The most common disease conditions in clinical trials are Anxiety Disorders, Cluster Headache, and Disease. The leading clinical trial sponsors are University Hospital, Basel, Switzerland, Matthias Liechti, and Psychiatric University Hospital, Zurich.

There are two hundred and seventy-five US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Lysergic Acid Diethylamide
TitleSponsorPhase
Effects of MDMA Co-administration on the Response to LSD in Healthy SubjectsUniversity Hospital, Basel, SwitzerlandPhase 1
Effect of Ketanserin After LSD AdministrationUniversity Hospital, Basel, SwitzerlandPhase 1
Comparative Acute Effects of LSD, Psilocybin and MescalineUniversity Hospital, Basel, SwitzerlandPhase 1

See all Lysergic Acid Diethylamide clinical trials

Clinical Trial Summary for Lysergic Acid Diethylamide

Top disease conditions for Lysergic Acid Diethylamide
Top clinical trial sponsors for Lysergic Acid Diethylamide

See all Lysergic Acid Diethylamide clinical trials

US Patents for Lysergic Acid Diethylamide

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Lysergic Acid Diethylamide   Start Trial Wearable apparatus for detecting a target substance in a liquid Undercover Colors, Inc. (Raleigh, NC)   Start Trial
Lysergic Acid Diethylamide   Start Trial Methods for treatment or prevention of damage resulting from radiation, trauma or shock SYNEDGEN, INC. (Claremont, CA)   Start Trial
Lysergic Acid Diethylamide   Start Trial Detection device for detecting analytes in liquid specimen Abon Biopharm (Hangzhou) Co., Ltd (Hangzhou, CN)   Start Trial
Lysergic Acid Diethylamide   Start Trial Tricyclic quinoline and quinoxaline derivatives ABBVIE DEUTSCHLAND GMBH & CO. KG (Wiesbaden, DE) ABBVIE INC. (North Chicago, IL)   Start Trial
Lysergic Acid Diethylamide   Start Trial Re-sealable container for a controlled substance having a child resistant lid N2 PACKAGING SYSTEMS, LLC (Twin Falls, ID)   Start Trial
Lysergic Acid Diethylamide   Start Trial N-pyridinyl acetamide derivatives as Wnt signalling pathway inhibitors Redx Pharma PLC (Macclesfield, GB)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Lysergic Acid Diethylamide

Drugname Country Document Number Estimated Expiration Related US Patent
Lysergic Acid Diethylamide Argentina AR107479 2036-01-27   Start Trial
Lysergic Acid Diethylamide Argentina AR107480 2036-01-27   Start Trial
Lysergic Acid Diethylamide Argentina AR107481 2036-01-27   Start Trial
Lysergic Acid Diethylamide Australia AU2017211860 2036-01-27   Start Trial
Lysergic Acid Diethylamide Australia AU2017212738 2036-01-27   Start Trial
Lysergic Acid Diethylamide Australia AU2017212742 2036-01-27   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Johnson and Johnson
Dow
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.